MAUDE adverse event: EDAN Instruments, Inc. - Patient Monitor

Reported to the FDA Oct 7, 2026. The FDA publishes these reports weeks after receipt. EDAN has identified a cybersecurity vulnerability that could allow an attacker to gain access privileges by placing a host on the same broadcast domain as the device. The vulnerabi